EUVIMEDEUVIMED entdecken
Open Access

Development of Phenoxyacetic Acid Hybrids With COX‐2 Inhibitory Activity as Potential Anti‐Neuroinflammatory Agents

Mohammad H Alqarni iD, Mahmoud Abdelrahman Alkabbani iD, Aya Mohamed Ahmed Ibrahim iD, Ahmed I Foudah iD, Tariq M Aljarba iD, Aftab Alam, Hatem A Abdel-Aziz iD, Mohamed K Elgohary iD

Drug Development Research · 2026

DOI: 10.1002/ddr.70363 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Development Research, 2026. Verfasst von Mohammad H Alqarni und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia. Hauptthemen laut MEDLINE: Cyclooxygenase 2 Inhibitors, Acetates, Anticonvulsants, Ethylene Glycols. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Prince Sattam bin Abdulaziz University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This research employs a molecular hybridization strategy to repurpose the pyrazoline scaffold 6a, 6c, 7a‐c, 11a, and 12b , transforming it into a high‐efficiency conjugate designed to tackle the multifaceted pathology of neuroinflammation and epilepsy. By integrating a selective phenoxyacetic acid moiety. Our findings identified compound 7c as a potential lead candidate for the development of novel anticonvulsant agents. In vivo trials demonstrated that 7c offers a superior therapeutic window compared to valproic acid, yielding 90% seizure protection in PTZ models and a remarkable 212.27% delay in seizure onset within the pilocarpine model, alongside 100% survival. Beyond mere symptomatic suppression, 7c re‐engineers the hippocampal environment by slashing glutamate‐driven excitotoxicity by 64.23% and silencing the cytokine‐glial activation axis (TNF‐alpha, IL‐6, GFAP, and Iba‐1). Supported by ADME profile confirming optimal BBB permeability and molecular docking indicating a robust binding affinity of −10.3 kcal/mol, this study positions 7c as a versatile, non‐toxic, and repurposed‐ready hybrid candidate for advanced neuroprotective intervention.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cyclooxygenase 2 InhibitorsAcetatesAnticonvulsantsEthylene GlycolsNeuroprotective AgentsNeuroinflammatory DiseasesAnti-Inflammatory AgentsAnimalsMolecular Docking SimulationSeizuresMaleRatsHippocampusMiceHumans

Stichwörter der Autor:innen

epilepsyglutamate releasephenoxy acetic acidpyrazolinetoxicity study

Substanzen

phenoxyacetic acidCyclooxygenase 2 InhibitorsAcetatesAnticonvulsantsEthylene GlycolsNeuroprotective AgentsAnti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Pharmacognosy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al Kharj, Saudi Arabia.
  • Pharmacology and Toxicology Department, Faculty of Pharmacy, Egyptian-Russian University, Badr City, Cairo, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Egyptian Russian University, Badr City, Cairo, Egypt.
  • Applied Organic Chemistry Department, National Research Center, Dokki, Cairo, Egypt.
  • Pharmaceutical Chemistry Department, Faculty of Pharmacy, Egyptian Russian University, Badr City, Cairo, Egypt.

ORCID-Profile: Mohammad H Alqarni, Mahmoud Abdelrahman Alkabbani, Aya Mohamed Ahmed Ibrahim, Ahmed I Foudah, Tariq M Aljarba, Hatem A Abdel-Aziz, Mohamed K Elgohary

Förderung

  • Prince Sattam bin Abdulaziz University

Zitieren

APA

Alqarni, M. H., Alkabbani, M. A., Ibrahim, A. M. A., Foudah, A. I., Aljarba, T. M., Alam, A., Abdel-Aziz, H. A., & Elgohary, M. K. (2026). Development of Phenoxyacetic Acid Hybrids With COX‐2 Inhibitory Activity as Potential Anti‐Neuroinflammatory Agents. Drug Development Research. https://doi.org/10.1002/ddr.70363

Vancouver

Alqarni MH, Alkabbani MA, Ibrahim AMA, Foudah AI, Aljarba TM, Alam A, et al. Development of Phenoxyacetic Acid Hybrids With COX‐2 Inhibitory Activity as Potential Anti‐Neuroinflammatory Agents. Drug Development Research. 2026. doi:10.1002/ddr.70363

BibTeX
@article{Alqarni2026,
  author = {Alqarni, Mohammad H and Alkabbani, Mahmoud Abdelrahman and Ibrahim, Aya Mohamed Ahmed and Foudah, Ahmed I and Aljarba, Tariq M and Alam, Aftab and Abdel-Aziz, Hatem A and Elgohary, Mohamed K},
  title = {Development of Phenoxyacetic Acid Hybrids With COX‐2 Inhibitory Activity as Potential Anti‐Neuroinflammatory Agents},
  journal = {Drug Development Research},
  year = {2026},
  doi = {10.1002/ddr.70363}
}
Kostenlos starten →